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Research
Inorganic arsenic is a recognized toxicant and 
carcinogen. Exposure to inorganic arsenic usu-
ally incurs obvious developmental and repro-
ductive toxicity (Willhite and Ferm 1984). 
People drinking arsenic-polluted well water 
showed an increased risk of type 2 diabetes 
in areas with high levels of arsenic in Taiwan 
and Bangladesh (Chen et al. 2007; Lai et al. 
1994; Navas-Acien et al. 2006; Rahman et al. 
1998). Chakraborti et al. (2003) found an 
increased incidence of miscarriages, stillbirths, 
preterm births, and low birth weights in off-
spring of women who drank water containing 
arsenic concentrations ranging from 463 to 
1,025 µg/L. Alterations in muscle fiber com-
position and size may contribute to the devel-
opment of type 2 diabetes in individuals with 
low birth weight (Jensen et al. 2007). Further 
study has shown that low-birth-weight piglets 
differentiate low numbers of muscle fibers dur-
ing prenatal myogenesis, and affected piglets 
do not exhibit post  natal “catch-up” growth 
(Rehfeldt and Kuhn 2006). Additionally, 
maternal under  nutrition before fetal muscle 
differentiation decreases the myoblast prolifera-
tion coupled with an earlier onset of differen-
tiation to fibers, alters development of muscle 
fibers, and reduces the birth weight of newborn 
lambs (Brameld et al. 2000; Fahey et al. 2005). 
Moreover, Ronco et al. (2009) recently reported 
that exposure to cadmium during pregnancy 
reduces birth weight and elevates both maternal 
and fetal glucocorticoid levels. Such embryonic 
exposure to increased gluco  corticoids might be 
related to low birth weight and later deleteri-
ous consequences in adult life (McTernan et al. 
2001; Seckl and Holmes 2007). Perinatal high-
dose dexa  methasone exposure could also alter 
develop  ment of skeletal muscles in rats (Steiss 
et al. 1989). Therefore, we hypothesize that 
alteration of skeletal myogenic differentiation 
may be involved in low birth weight after expo-
sure to arsenic and that arsenic may also alter 
muscle regeneration.
Arsenic trioxide (As2O3) induces differen-
tiation of promyelocytic leukemia cells (Chen 
et al. 1997) and suppresses the differentiation 
of human keratinocytes (Kachinskas et al. 
1994, 1997) and murine adipocytes (Trouba 
et al. 2000). A recent report indicated that 
arsenic exposure alters the expression or activ-
ity of different genes and proteins expressed 
in muscle and fat tissues (Diaz-Villasenor 
et al. 2007). However, the precise mechanism 
of action of arsenic on skeletal myogenic dif-
ferentiation remains unknown.
Myogenesis is a process that involves three 
major steps: withdrawal of myoblasts from the 
cell cycle, subsequent expression of myotube-
specific genes, and formation of multi  nucleated 
myotubes (Weintraub 1993; Weintraub et al. 
1991). Myogenesis is largely regulated by the 
myogenic basic helix-loop-helix family of tran-
scription factors (MyoD, myogenin, myf5, and 
MRF4) and myocyte enhancer factor 2, which 
regulate the expression of many muscle-specific 
genes, such as the myosin heavy chain (MHC) 
and creatine kinase (Lassar et al. 1994; Olson 
et al. 1995). Cell division is prevented dur-
ing muscle differentiation by the induction 
of cyclin-dependent protein kinase inhibitors 
(Franklin and Xiong 1996; Halevy et al. 1995). 
Furthermore, the absence of myogenin reduces 
MHC expression and myotube formation, 
indicating that myogenin has a unique func-
tion in the transition from a determined myo-
blast to a fully differentiated myotube (Davie 
et al. 2007; Myer et al. 2001). Moreover, phos-
phatidylinositol 3-kinase (PI3K)/Akt (protein 
kinase B)–related signaling is thought to have 
a key role in the control of muscle gene expres-
sion during myogenic differentiation (Kaliman 
et al. 1996; Tamir and Bengal 2000). Altered 
PI3K/Akt signaling is also found in the skeletal 
muscle of young men with low birth weight 
(Jensen et al. 2008). Based on these cumulative 
results, in our present study we investigated the 
mechanism of action of As2O3 on the mor-
phologic and biochemical differentiation of 
myoblastic cells in vitro and in an in vivo mouse 
model with skeletal muscle regeneration after 
glycerol injury. The results showed that As2O3 
is capable of inhibiting skeletal myogenic differ-
entiation by inhibiting Akt-regulated signaling.
Materials and Methods
Cell cultures. C2C12 mouse myoblasts. Cells 
were obtained from American Type Culture 
Collection (Manassas, VA, USA) and cultured 
in growth medium consisting of Dulbecco’s 
modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS) 
and anti  biotics (100 IU/mL penicillin, 
100 µg/mL streptomycin) in 5% carbon diox-
ide (CO2) at 37°C.
Primary myoblasts. Murine skeletal mus-
cle tissues were obtained from the forelimb 
and hind limb of neonatal mice (2–5 days of 
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Ba c k g r o u n d: The incidence of low birth weights is increased in offspring of women who are exposed 
to high concentrations of arsenic in drinking water compared with other women. We hypothesized 
that effects of arsenic on birth weight may be related to effects on myogenic differentiation.
oB j e c t i v e: We investigated the effects of arsenic trioxide (As2O3) on the myogenic differentiation 
of myoblasts in vitro and muscle regeneration in vivo.
Me t h o d s : C2C12 myoblasts and primary mouse and human myoblasts were cultured in dif-
ferentiation media with or without As2O3 (0.1–0.5 µM) for 4 days. Myogenic differentiation was 
assessed by myogenin and myosin heavy chain expression and multinucleated myotube formation 
in vitro; skeletal muscle regeneration was tested using an in vivo mouse model with experimental 
glycerol myopathy.
re s u l t s: A submicromolar concentration of As2O3 dose-dependently inhibited myogenic differenti-
ation without apparent effects on cell viability. As2O3 significantly and dose-dependently decreased 
phosphorylation of Akt and p70s6k proteins during myogenic differentiation. As2O3-induced 
inhibition in myotube formation and muscle-specific protein expression was reversed by transfec-
tion with the constitutively active form of Akt. Sections of soleus muscles stained with hematoxylin 
and eosin showed typical changes of injury and regeneration after local glycerol injection in mice. 
Regeneration of glycerol-injured soleus muscles, myogenin expression, and Akt phosphorylation 
were suppressed in muscles isolated from As2O3-treated mice compared with untreated mice.
co n c l u s i o n: Our results suggest that As2O3 inhibits myogenic differentiation by inhibiting Akt-
regulated signaling.
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age). Skeletal muscle biopsies (~ 0.2 g) were 
obtained from a 60-year-old female patient 
during orthopedic surgery at the National 
Taiwan University Hospital, with approval 
from the institutional ethical committee and 
informed consent from the patient. Different 
populations of muscle-derived cells have been 
isolated based on their adhesion characteristics 
and proliferation behaviors by Qu-Petersen 
et al. (2002). Here, the cells of an early preplate 
population, which possesses satellite cell charac-
teristics (Qu-Petersen et al. 2002), were isolated 
and cultured for myogenic cell differentiation 
as described by Qu-Petersen et al. (2002). In 
brief, the muscles cleaned from the surround-
ing connective tissue were minced with sharp 
scissors to obtain fragments approxi  mately 
1 mm in diameter. Enzymatic digestion was 
carried out in Ham’s F10 medium (Invitrogen, 
Carlsbad, CA, USA) containing 0.2% collage-
nase (type XI; Sigma-Aldrich, St. Louis, MO, 
USA) plus 0.03% EDTA at 37°C for 1 hr with 
occasional shaking, and then centrifuged at 
600 × g for 5 min. The cells were collected and 
incubated in dispase (Invitrogen) solution for 
45 min and then incubated in 0.1% trypsin-
EDTA for 30 min. The filtrate was spun at 
600 × g for 5 min to sediment the dissociated 
cells. The pellet was resuspended in growth 
medium [Ham’s F-10 supplemented with 20% 
FBS, 2.5 ng/mL basic fibroblast growth fac-
tor (R&D Systems, Minneapolis, MN, USA), 
and 1% penicillin-streptomycin (Invitrogen)] 
in 5% CO2 at 37°C; the suspension was then 
plated on collagen-coated dishes. The cells with 
positive desmin (myogenic marker) staining 
were used for identification of myogenic dif-
ferentiation.
Myogenic differentiation and As2O3 treat-
ment. For myogenic differentiation, C2C12 
myoblasts and primary myoblasts were placed 
in a differentiation medium consisting of 
an equal mixture of two serum-free media 
(Nutrient Mixture F-12K Ham medium and 
MCDB201; Invitrogen) along with 2% horse 
serum to induce differentiation with or with-
out As2O3 (0.1–0.5 µM) treatment. After 
4 days of treatment, myoblast differentiation 
was determined morphologically by analysis of 
multi  nucleated myotube formation. We ana-
lyzed cells morphologically by hematoxylin and 
eosin (H&E) staining; H&E stains nuclei deep 
purple and protein pink, giving a good indica-
tion of overall myogenic progression.
Protein extraction and immunoblotting. 
Cells were washed with phosphate-buffered 
saline (PBS) and lysed with RIPA buf-
fer [10 mM Tris (pH 7.4), 150 mM NaCl, 
1 mM ethylene glycol tetraacetic acid, 0.1% 
sodium dodecyl sulfate (SDS), 1 mM NaF, 
1 mM sodium orthovanadate, 1 mM phenyl-
methyl  sulfonyl fluoride (PMSF), 1 µg/mL 
aprotinin, and 1 µg/mL leupeptin]. In this 
buffer, NaF and PMSF were the phosphatase 
inhibitor and serine protease inhibitor, respec-
tively. The cell suspension was left on ice for 
20 min and then centrifuged at 10,000 × g 
for 20 min at 4°C. We used the supernatant 
for the experiments. An equal amount (40 µg) 
of protein was separated by 10% SDS-PAGE 
and electro  transferred onto polyvinylidene dif-
luoride membrane (0.2 µm) using transfer 
buffer (192 mM glycine, 25 mM Tris, 20% 
methanol, pH 8.3) followed by blocking in 
TBST (Tris-buffered saline/Tween-20) buf-
fer (20 mM Tris, 150 mM NaCl, 0.01% 
Tween-20, pH 7.5) supplemented with 5% 
non  fat powdered milk. The membranes were 
then probed with the primary anti  bodies [anti-
extracellular signal-regulated kinase (ERK), 
anti-Akt, anti-phosphorylated Akt (Ser473), 
anti-myogenin, and anti-MHC; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA] over-
night at 4°C, followed by incubation with 
the secondary goat anti-rabbit or anti-mouse 
anti  bodies conjugated with horseradish per-
oxidase. The blots were developed using an 
enhanced chemiluminescence reagent detec-
tion system according to the manufacturer’s 
protocol (Millipore Corporation, Billerica, 
MA, USA). Densitometric analysis was car-
ried out using Molecular Analyst software 
Figure 1. Inhibitory effect of As2O3 on myogenic differentiation in C2C12 cells; cells were cultured in differ-
entiation medium in the presence or absence of As2O3 (0.1, 0.3, or 0.5 µM). (A) Cell morphology examined by 
H&E staining at 96 hr; arrows indicate multinucleated myotube formations. (B) Number of nuclei per myo-
tube. (C) Number of myotubes formed per field, calculated from three random fields per treatment. Data are 
mean ± SE of three independent experiments. 
*p < 0.05 compared with control. 
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(version 1.3; BioRad, Hercules, CA, USA). 
The extent of phosphorylation in terms of rela-
tive band intensity was quantified by scanning 
densitometry using a GS-670 imaging densi-
tometer (BioRad, Hercules, CA, USA), with 
an arbitrary value of 1.0 given to the respective 
control samples of each experiment.
Creatine kinase activity assay. Cells were 
washed twice in cold PBS and lysed in lysis 
buffer. Lysates were centrifuged for 10 min at 
13,000 × g, the supernatants were collected, 
and the protein contents in the samples were 
measured using bicinchoninic acid protein 
assay reagent (Thermo Scientific, Rockford, IL, 
USA). Creatine kinase activity was measured 
using a commercial kit (Teco Diagnostics, 
Anaheim, CA, USA). We calculated the activ-
ity of creatine kinase (units per milligram of 
protein) after correction for total protein. 
Immunocytochemistry. Cells cultured in 
6- or 12-well dishes were washed with PBS 
followed by fixation for 10 min with 4% para-
formaldehyde in PBS. Cells were then washed 
three times for 1 min each with PBS and per-
meabilized in PBS containing 0.2% Triton 
X-100/PBS for 5 min at room temperature. 
After three washes for 1 min each with PBS, 
cells were blocked with 5% bovine serum 
albumin in PBS plus 0.2% Triton X-100 
for 30 min and then incubated overnight at 
4°C with polyclonal rabbit anti-myogenin 
and anti-MHC primary anti  bodies diluted 
with blocking solution to 1:100. After four 
additional washes with PBS, cells were incu-
bated for 1 hr at room temperature in the dark 
with goat anti-rabbit IgG1-fluorescein iso-
thiocyanate secondary anti  bodies diluted in 
blocking solution to 1:1,000. 4´,6´-Diamino-
2-phenylindole-2HCl (DAPI) nuclear dye 
was added with secondary anti  bodies at a final 
concentration of 400 ng/mL. Finally, cells 
were washed three times in PBS. Fluorescent 
images were captured by a Leica DMIL 
inverted microscope equipped with a charged-
coupled device camera and SPOT software, 
version 4.6 (Diagnostic Instruments, Sterling 
Heights, MI, USA).
Transient transfection. We performed 
transient transfections using a Lipofectamine 
2000 reagent (Invitrogen) following the manu-
facturer’s instructions. Briefly, 5 × 105 cells 
were seeded in six wells and incubated at 37°C 
in 5% CO2. After rinsing with serum-free and 
antibiotic-free medium, the cells were trans-
fected separately with a control pcDNA3.1   
empty vector or a constitutively active form 
of Akt [myristoylated (myr) Akt], which was 
a gift from J.L. Ko (Chung Shan Medical 
University, Taichung, Taiwan) and M.L. Kuo 
(National Taiwan University, Taipei, Taiwan) 
(Kuo et al. 2001), and incubated at 37°C in 
5% CO2 for 6 hr. The medium was replaced 
with DMEM containing 10% FBS. We 
determined the efficiency of transfection 
(~ 40–50%) using an equal amount of a plas-
mid encoding the green fluorescent protein 
under the cytomegalovirus promoter.
Arsenic-treated mice. Male ICR mice   
(20–25 g body weight) were purchased from 
the Animal Center of the College of Medicine, 
National Taiwan University (Taipei, Taiwan). 
The Animal Research Committee of the 
College of Medicine conducted the study 
in accordance with the Guide for the Care 
and Use of Laboratory Animals (Institute of 
Laboratory Animal Resources 1996). The 
animals were treated humanely and with 
regard for alleviation of suffering. Mice were 
housed in a room at a constant temperature 
of 22 ± 2°C with 12-hr light/dark cycles. 
Mice were exposed to As2O3 through drink-
ing water containing 0.5 or 5 ppm (dissolved 
in distilled water) for 8 consecutive weeks 
(n = 16 mice/group). To prevent or minimize 
oxidation of As2O3, the water containing 
As2O3 was freshly prepared every 3–4 days.
Experimental glycerol myopathy. Skeletal 
muscle injury and regeneration in mice were 
induced by glycerol injection according to 
a modification of the method described by 
Kawai et al. (1990). Glycerol (0.1 mL of 50%,   
vol/vol) was injected into the mouse soleus 
muscle under ketamine (30 mg/kg) and 
xylazine (4 mg/kg) anesthesia. Contralateral 
muscles served as controls for each animal. 
Mice were sacrificed 3, 5, or 12 days after 
glycerol injection, and the soleus muscles were 
removed. Arsenic exposure continued dur-
ing glycerol injection until sample collection. 
We recorded body weights and the weights 
of skeletal muscles. Some muscles were fixed 
in 10% formalin and embedded in paraffin. 
Sections (5 µm) were cut in the middle part of 
the muscle belly (fleshy part of the muscle) to 
obtain the largest cross-section area and then 
stained with H&E or with Masson’s trichrome 
to detect collagen (fibrosis). The myofibers 
containing centralized nuclei in soleus muscles 
isolated from mice were assessed under high-
powered field (200× magnification; five fields 
per sample).
Measurement of cell viability. Cell viability 
was determined by a colorimetric assay using 
3-(4,5-dimethyl thiazol-2-yl)- 2,5-diphenyl 
tetrazolium bromide (MTT) (Sigma). In brief, 
cells were seeded at 104 cells/well in 96-well 
plates and incubated in culture medium over-
night. The cells were then switched to DM 
and treated with varying doses of As2O3 and 
observed after 96 hr. This assay measures the 
activity of living cells via mitochondrial dehy-
drogenase activity that reduces MTT to purple 
formazan. The formazan was solubilized by 
DMSO, and its absorbance at 570 nm was 
measured.
Statistics. Data are expressed as mean ± SE. 
We assessed the significant difference from the 
respective controls for each experimental test 
condition using analysis of variance and the 
Bonferroni t-test, with p < 0.05 considered 
significant.
Results
Arsenic inhibits myogenic differentiation in 
myoblastic cells. We assessed the myogenic dif-
ferentiation of C2C12 myoblastic cells cultured 
in differentiation medium morphologically 
by the alignment, elongation, and fusion of 
mononucleated myoblasts into multi  nucleated 
myotubes. After 4 days, we examined myo-
tube formation by H&E staining (Figure 1A), 
nuclei per myotube (Figure 1B), number of 
myotubes per field (Figure 1C), and creatine 
kinase activity, a marker of myoblast differ-
entiation (Figure 2A). As2O3 (0.1–0.5 µM) 
significantly inhibited myotube formation in 
a dose-dependent manner (Figure 1) but did 
not affect the viability of C2C12 cells dur-
ing myogenic differentiation (methylthiotetra-
zole assay: day 4, As2O3 0.1, 0.3, and 0.5 µM; 
101.6 ± 2.3%, 97.8 ± 4.6%, and 96.1 ± 3.9% 
of control, respectively). 
Figure 2. Inhibitory effect of As2O3 on creatine kinase activity and expression of MHC proteins during myo-
genic differentiation in C2C12 myoblasts; cells were cultured in growth medium (GM; day 0) or differentia-
tion medium (DM) in the presence or absence of As2O3 (0.1, 0.3, or 0.5 µM) for 1, 2, or 4 days. (A) Activity 
of creatine kinase. (B) Expression of MHC proteins, examined by Western blotting; ERK was used as the 
loading control. Expression of MHC proteins was quantified by densitometric analysis. Data are mean ± SE 
for four independent experiments. 
*p < 0.05 compared with arsenic-unexposed DM control.
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To further characterize the inhibitory effect 
of As2O3 on myogenic differentiation, we 
examined the effect of As2O3 on the expres-
sion of MHC, a late biochemical marker of 
myogenesis, during myogenic differentiation. 
MHC expression was detected in C2C12 myo-
blasts (Figure 2B), primary mouse myoblasts 
(Figure 3A), and human myoblasts (Figure 3B) 
during myogenic differentiation. As2O3   
(0.1–0.5 µM) suppressed the expression of 
MHC in these myoblastic cells. Moreover, 
myogenin has been shown to induce the 
expression of the muscle structural gene MHC 
in Xenopus laevis (Charbonnier et al. 2002). We 
next investigated the effect of As2O3 on myo-
genin expression during myogenic differen-
tiation using immuno  cytochemistry (Figure 4) 
and Western blotting (Figure 5A). As2O3 
(0.1–0.5 µM) significantly decreased myogenin 
expression during myogenic differentiation in a 
dose-dependent manner (Figures 4, 5A). These 
results indicated that a sub  micromolar concen-
tration of As2O3 is capable of inhibiting myo-
blast differentiation and myotube formation.
As2O3 inhibits phosphorylation of Akt, 
mTOR (mammalian target of rapamycin), 
and p70s6k. Akt can substitute for PI3K in 
the stimulation of myogenesis, and it may be 
an essential downstream component of PI3K-
induced muscle differentiation (Jiang et al. 
1999). Therefore, we investigated the effects 
of As2O3 on the phosphorylation of Akt and 
its downstream signals, mTOR and p70s6k, 
during myogenic differentiation. Moreover, 
Gonzalez et al. (2004) demonstrated that, dur-
ing myoblast differentiation, Akt kinase activ-
ity correlated with Ser473 but not Thr308 
phosphorylation. Therefore, we checked Akt 
(Ser473) phosphorylation during myoblast 
differentiation. As shown in Figure 5B, Akt 
protein phosphorylation was gradually acti-
vated during myogenic differentiation. As2O3 
(0.1–0.5 µM) significantly decreased the phos-
phorylation of Akt (Figure 5B) and its down-
stream targets, mTOR and p70s6k proteins, 
during myogenic differentiation in a dose-
dependent manner Figure 6B). These results 
imply that As2O3 inhibits myogenic differen-
tiation by inhibiting an Akt-related pathway.
To further confirm the role of Akt sig-
naling in arsenic-induced inhibition of myo-
genesis, the constitutively active form of 
Akt was over  expressed in C2C12 myoblas-
tic cells. Transfection with a constitutively 
active form of Akt (c.a. Akt) enhanced myo-
tube formation (Figure 7A), creatine kinase 
activity (Figure 7B), and MHC expression 
(Figure 6A) during myogenesis, and effec-
tively antagonized the myogenesis inhibition 
induced by 0.5 µM As2O3 (Figures 6A, 7).
Figure 3. Inhibitory effect of As2O3 on the expression of MHC proteins in primary mouse (A) and human (B) 
myoblasts during myogenic differentiation shown in merged MHC/DAPI images. Results are representative 
of three independent experiments.
100 µm
100 µm
As2O3 (µM)
As2O3 (µM)
0 0.1
Mouse
Human
0.3 0.5
0 0.1 0.3 0.5
Figure 4. Inhibitory effect of As2O3 on the expression of myogenin proteins during myogenic differentiation in C2C12 cells; cells were cultured in differentiation 
medium (DM) for 4 days with or without As2O3 treatment (0.1–0.5 µM). (A) Myogenin expression examined by immunocytochemistry: Top, myogenin expression 
(green fluorescence); bottom, nuclei stained with DAPI (blue fluorescence). (B) Quantification of myogenin expression on day 4 during myogenic differentiation, 
showing the fraction of myogenin-positive nuclei. Data are mean ± SE of four independent experiments; at least 500 cells in each group were counted. 
*p < 0.05 compared with control.
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Arsenic affects skeletal muscle regenera-
tion and function in vivo. Muscle regenera-
tion in soleus muscle was induced following 
glycerol injection, which causes extensive and 
reproducible muscle necrotic injury. The 
myogenic differentiation is initiated within 
2 days followed by extensive regenera-
tive changes within 7–14 days after glycerol 
injection (Kawai et al. 1990). Glycerol was 
injected into soleus muscles of control and 
As2O3-treated mice (0.5 and 5 ppm As2O3
 
in drinking water for 8 weeks). We observed 
an increase of myogenin expression and 
Akt phosphorylation in the soleus muscles 
on day 3 after glycerol injection, but it was 
suppressed in As2O3-treated mice compared 
with control mice (Figure 8). Moreover, 
H&E-stained cross sections of soleus mus-
cles showed the typical signs of injury and 
regeneration on day 5 after glycerol injection, 
as indicated by chronic inflammation (infil-
tration of mono  nucleated cells) and newly 
formed myofibers with centralized nuclei, 
as well as nearly complete regeneration on 
day 12, as indicated by the largely restored 
muscle architecture (Figure 9A). Soleus mus-
cles isolated from As2O3-treated mice dis-
played a reduction in myofibers containing 
centralized nuclei [myofiber regeneration; 
number (mean ± SE) of regenerating myo-
fibers per high-powered field: control, 
52.25 ± 3.57; 0.5 ppm As2O3,41.50 ± 6.33; 
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Figure 5. Inhibitory effect of As2O3 on myogenin pro-
tein expression and phosphorylation of Akt protein 
during myogenic differentiation in C2C12 cells; cells 
were cultured in growth medium (GM; day 0) or dif-
ferentiation medium (DM) for 4 days with or without 
treatment with As2O3 (0.1–0.5 µM). (A) Myogenin 
protein expression during myogenic differentiation 
(days 1, 2, and 4) analyzed by Western blotting; 
ERK was used as the loading control. Results are 
representative of three independent experiments. 
(B) Phosphorylation of Akt protein examined by 
Western blotting (top) and quantification of pro-
tein expression by densitometric analysis (bottom); 
results represent the fold increase in proteins rela-
tive to the untreated group in GM after normal-
ization to the loading control (ERK1/2). Data are 
mean ± SE of four independent experiments. 
*p < 0.05 compared with corresponding arsenic-
  unexposed controls.
Figure 6. Inhibitory effect of As2O3 on MHC expression in myoblasts transfected with c.a. Akt and the phos-
phorylation of mTOR and p70s6k proteins during myogenic differentiation. (A) Expression of endogenous 
and mutant proteins in cell lysates analyzed by Western blotting with anti-Akt and phosphorylated Akt 
(p-AktSer473) antibodies; MHC protein expression was also detected. Equal loading was confirmed by 
reprobing with anti-β-actin antibody. (B) Phosphorylation (p-) of mTOR and p70s6k proteins examined by 
Western blotting. All results are representative of three independent experiments. 
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Figure 7. Overexpression of c.a. Akt rescues the inhibitory effect of As2O3 on myogenic differentiation in 
C2C12 cells transiently transfected with control pcDNA3.1 or c.a. Akt in GM for 24 hr. Cells were allowed 
to differentiate in differentiation medium (DM) in the presence or absence of As2O3 (0.5 µM) for 4 days. 
(A) Myotubes detected after 4 days in a myogenic differentiation condition; data are representative of at 
least three independent experiments with similar results. (B) Creatine kinase activity; data are mean ± SE 
for four independent experiments. 
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5 ppm As2O3, 17.25 ± 10.63; p < 0.05 vs. 
control; n = 4). In Masson’s trichrome-stained 
sections on day 12 after glycerol injection, col-
lagen (fibrosis marker) was distributed mainly 
around the fat deposits in the injured muscles 
(Figure 9B). The collagen-stained area (fibro-
sis formation) in soleus muscles isolated from 
As2O3-treated mice were obviously larger than 
those in control soleus muscles (Figure 9B). 
Discussion
Low-dose As2O3 (0.25 and 0.5 µM) has been 
reported to activate the transcription of genes 
involved in adipose differentiation (Salazard 
et al. 2004). In contrast, Wang et al. (2005) 
Figure 9. Inhibition of muscle regeneration after glycerol injury in mice treated with As2O3 (0.5 and 5 ppm) for 8 weeks. See “Materials and Methods” for details. 
(A) Muscle morphology of soleus sections (H&E) before and 5 or 12 days after glycerol injection; centrally localized nuclei indicate myofiber regeneration (arrows). 
(B) Masson’s trichrome staining for collagen (collagen, blue; myofibers, red; nuclei, black). Collagen (fibrosis marker) was distributed around the fat deposits in the 
injured muscles; note the dense blue-stained fibrous tissue in the As2O3 (0.5 and 5 ppm) groups (arrows). Results are representative of three independent experiments. 
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Figure 8. As2O3 inhibits muscle regeneration after glycerol injury in mice treated with As2O3 (0.5 and 5 ppm) 
for 8 weeks. See “Materials and Methods” for details. (A) Myogenin expression and Akt phosphorylation 
in soleus muscles of arsenic-treated mice 3 days after glycerol injection, analyzed by Western blotting. 
(B) Myogenin and phosphorylated Akt proteins quantified by densitometric analysis; results represent pro-
tein expression in treated animals relative to untreated controls after normalization to the loading control. 
Data are mean ± SE for four independent experiments. 
*p < 0.05 compared with control. 
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reported that As2O3 (3 µM) did not induce 
apoptosis but inhibited differentiation of pre-
adipocyte 3T3-L1 cells. As2O3 also has been 
reported to exert dose-dependent dual effects 
on acute pro  myelocytic leukemia cells, induc-
ing apoptosis at relatively high concentrations 
(0.5–2 µM) and inducing partial differentia-
tion at low concentrations (0.1–0.5 µM) (Chen 
et al. 1997). In addition, high concentrations 
of As2O3 (30, 60, and 90 µM) for various peri-
ods (24, 48, and 72 hr) caused apoptosis in 
cardio  myocytes in a dose- and duration-de-
pendent manner (Raghu and Cherian 2009). 
However, the precise action of inorganic arse-
nic on skeletal muscle differentiation remains 
unclear. In the present study, we first dem-
onstrated that low-dose As2O3 (0.1–0.5 µM) 
dose-dependently inhibited in vitro skeletal 
muscle differentiation as assessed by myogenin 
and MHC expression, creatine kinase activ-
ity, and formation of multi  nucleated myo-
tubes without apparent effects on cell viability. 
Kawai et al. (1990) showed that the exten-
sive regenerative changes in glycerol-induced 
experimental myopathy, which we observed at 
7–14 days after glycerol injection, are similar 
to those seen in muscles from patients with 
Duchenne muscular dystrophy. In the present 
study, using morphologic examination, we also 
found that As2O3 (0.5 and 5 ppm) effectively 
suppressed myogenin expression and retarded 
muscle regenera  tion in mouse soleus muscles 
after injury by glycerol. These results suggest 
that As2O3 is capable of inhibiting skeletal 
muscle differentiation and retarding muscle 
regeneration.
PI3K and Akt are important signaling 
molecules in the regulation of proliferation 
and differentiation in various kinds of cells 
(Dummler and Hemmings 2007; Rivard 
2009). The Akt-related pathway has been 
shown to be involved in As2O3-induced inhi-
bition of 3T3-L1 pre  adipocyte differentia-
tion (Wang et al. 2005). In a recent report, 
Sandoval et al. (2007) indicated that sodium 
arsenite triggered the increment or decre-
ment of p53 binding to DNA to affect pro-
liferation or differentiation in epithelial cells 
through an Akt-related signaling pathway. 
Previous studies demonstrated an important 
role of PI3K signaling in myogenesis during 
an early step of terminal differentiation of 
skeletal muscle cells (Kaliman et al. 1996, 
1998). Jiang et al. (1999) further indicated 
that serine/threonine protein kinase Akt, a 
downstream target of PI3K, can substitute 
for PI3K in the stimulation of myogenesis. 
Those authors reported that transfection of 
myr Akt in chicken embryo fibroblasts dra-
matically enhanced myotube formation and 
expression of the muscle-specific proteins 
MyoD, creatine kinase, MHC, and desmin. 
In contrast, transfection of the dominant- 
negative form of Akt decreased the expression 
of muscle-specific proteins and myotube 
formation, suggesting that Akt may be an 
essential downstream component of PI3K-
regulated skeletal muscle differentiation. 
Reduced Akt activation was also associated 
with inhibition of C2C12 myoblast differ-
entiation (Sumitani et al. 2002). Peng et al. 
(2003) reported that dwarfism, impaired skin 
development, skele  tal muscle atrophy, delayed 
bone development, and impeded adipogen-
esis occurred in mice lacking Akt1 and Akt2. 
Moreover, activation of Akt in response to 
insulin stimulation has been shown to involve 
the phos  phory  la  tion of Ser473 and Thr308 
residues (Toker and Newton 2000). Paul et al. 
(2007) also reported that 4-hr exposures to 
50 µM arsenite or 2 µM methylarsonous acid 
inhibited insulin-dependent phosphorylation 
of Akt on both Ser473 and Thr308 residues in 
3T3-L1 adipocytes. However, Gonzalez et al. 
(2004) demonstrated a specific increase in 
Akt2 protein levels during myoblast differen-
tiation in which Akt kinase activity was corre-
lated with phosphorylation of Ser473 but not 
Thr308. Furthermore, Bodine et al. (2001) 
suggested that Akt-activated mTOR signal-
ing and its downstream targets p70s6k and 
PHAS-1/4E-BP1 are the crucial regulators 
of skele  tal muscle hypertrophy and that Akt/
mTOR activation can prevent skeletal mus-
cle atrophy induced by disuse. In the pres-
ent study, we found that a sub  micromolar 
concentration of As2O3 significantly and 
dose-dependently decreased phosphorylation 
of Akt protein and its downstream targets, 
mTOR and p70s6k, during myogenic differ-
entiation. The Akt (Ser473) phosphorylation 
was suppressed by As2O3 during myoblast 
differentiation. Overexpression of c.a. Akt 
enhanced myotube formation, creatine 
kinase activity, and MHC expression during 
myo  genesis and antagonized As2O3-induced 
myogenesis   inhibition.
Skeletal muscle regeneration is a known 
adaptive response to muscle injury that occurs 
through a process of myofiber degeneration, 
inflammation, and new myofiber formation 
resulting from satellite cell proliferation and 
differentiation (Hurme and Kalimo 1992; 
Kawai et al. 1990). However, fibrosis that 
also develops during the healing process may 
hinder muscle regeneration (Chan et al. 2003; 
Kasemkijwattana et al. 1998). In the pres-
ent study, we used an experimental glycerol 
myopathy model to investigate the effect of 
As2O3 on skeletal muscle injury and regenera-
tion. Intramuscular injection of 50% glycerol 
caused extensive muscle fiber necrosis and 
loss of muscle mass, which requires myo-
genesis during the initial phase of recovery 
to restore muscle mass (Kawai et al. 1990). 
Our results indicate that As2O3 in drink-
ing water impaired muscle regeneration and 
increased fibrosis (based on increased collagen 
staining) in a murine model of glycerol injury. 
Moreover, the increase in Akt phosphoryla-
tion observed 3 days after glycerol injection 
in the soleus muscles of control animals was 
markedly suppressed in animals treated with 
As2O3. Therefore, these results suggest that 
As2O3 inhibited myogenic differentiation by 
inhibiting an Akt-dependent pathway.
Conclusions
Akt is an important signaling pathway 
involved in myogenesis. Here, we found that 
a sub  micromolar concentration of As2O3 
significantly and dose-dependently inhib-
ited myogenic differentiation by inhibiting 
an Akt signaling pathway. Moreover, As2O3 
suppressed skeletal muscle differentiation and 
regeneration after injury in an in vivo mouse 
skeletal muscle regeneration model. Taken as a 
whole, these in vitro and in vivo findings sug-
gest that As2O3 may be an environmental risk 
factor for myogenesis.
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